$CHYM

DST Global Advisors Ltd sold $58.6M of CHYM (indirect holdings)

DST Global Advisors Ltd sold 1,796,196 indirectly-held shares of Chime Financial, Inc. (CHYM) at an average of $32.62 ($32.50–$33.13, $58.59M total) across 14 trades on 2026-08-06.

Original reporting
SEC EDGAR · DST Global Advisors Ltd
Published Aug 10, 2026, 11:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 11:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHYM
Neutral
medium confidence
Mentioned
$CHYM
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHYMNeutralLow
01

Why it matters

A 10% owner sold about $58.6M of CHYM at roughly $32.50 to $33.13 per share, leaving 471,952 shares indirectly after the transaction.

02

Market read

Traders may monitor CHYM for follow-on selling or changes in ownership, but the filing alone does not update fundamentals.

03

What to watch

Because the sale is indirect and across multiple trades, it may reflect pre-planned portfolio management rather than a directional view; traders should watch for subsequent filings for pattern confirmation.

Relevance 8/10Novelty 5/10Timing: filed Aug 10, transaction dated Aug 6

Background

The article is an SEC Form 4 insider transaction disclosure for Chime Financial, Inc. (CHYM).

Company-level read

Ticker impact

$CHYMNeutralMedium confidence
Context

DST Global Advisors, a 10% owner, sold $58.6M of Chime Financial shares via an open-market sale reported on Form 4.

Expected impact

Near-term sentiment risk is modest; any price reaction is likely limited unless follow-on selling continues or other fundamentals change.

Evidence & confidence

The filing discloses transaction size, price range, and post-sale holdings, but provides no new operating, guidance, or regulatory information.

Market effects

Minimal, as this is a single-company insider-sale disclosure without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The sale may be liquidity-driven (taxes, diversification) and does not necessarily signal reduced confidence, especially since the filing does not cite any negative company development.

Key entities

  • Chime Financial, Inc.

    US-listed company whose shares were sold by a 10% owner via indirect holdings.

  • DST Global Advisors Ltd

    10% owner reporting an open-market sale of CHYM shares via indirect holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHYMHigh

Why is Chime Financial stock gaining today?

Chime Financial (CHYM) stock rose 1.5% in pre-market trading after Deutsche Bank upgraded it to Buy and raised its price target to $35. The bank cited strong Q2 2026 results, including 27% revenue growth and GAAP profitability, as well as growth in MyPay and Chime Prime. The upgrade also boosted FY27 adjusted EBITDA estimates by $71 million.

$CHYMMed

Deutsche Bank Upgrades Chime (CHYM) to Buy, Raises Price Target

Deutsche Bank upgraded Chime Financial Inc (CHYM) to Buy, raising its price target to $35. The bank cited strong product momentum and market expansion potential, particularly with MyPay and Chime Prime. Chime's P/S ratio is 4.85, above its historical and industry medians, reflecting growth expectations. Insider activity shows significant net selling, while institutional ownership trends are mixed.

$CHYMMed

Chime Financial Slides as Recent Insider Sales Likely Weigh on Shares

Chime Financial (CHYM) shares fell 7.5% today, likely due to recent insider and major-holder sales, including 3.2 million shares sold by DST Global and 447,637 shares by director James Feuille. The decline follows Chime's announcement of a $590 million bank acquisition, with no new negative updates reported. Analysts' median price target for CHYM is $28.0.